Revised SPCs: Cabometyx (cabozantinib) Film-coated Tablets- all strengths

SPC revised to warn osteonecrosis of jaw (ONJ) has been observed with cabozantinib. Oral exam should be performed prior to initiation and periodically during therapy. Patients should be advised on oral hygiene practice. Caution needed with concomitant use of agents liked to ONJ


electronic Medicines compendium